{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:16:38Z","timestamp":1792030598441,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000004"],"award-info":[{"award-number":["UL1 TR000004"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ymgme.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T13:32:28Z","timestamp":1453728748000},"page":"438-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS)"],"prefix":"10.1016","volume":"117","author":[{"given":"Rossella","family":"Parini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Mendelsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.01.009_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0010","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ajmg.a.32781","article-title":"Incidence of the mucopolysaccharidoses in Taiwan, 1984\u20132004","volume":"149A","author":"Lin","year":"2009","journal-title":"Am. J Med Genet A"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0025","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/j.1651-2227.2011.02522.x","article-title":"Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status","volume":"101","author":"Marucha","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0030","first-page":"273","article-title":"Prospective study of 11 Brazilian patients with mucopolysaccharidosis II","volume":"82","author":"Pinto","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-8749.1983.tb13794.x","article-title":"The natural history of the severe form of Hunter's syndrome: a study based on 52 cases","volume":"25","author":"Young","year":"1983","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0040","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/adc.57.11.828","article-title":"Mild form of Hunter's syndrome: clinical delineation based on 31 cases","volume":"57","author":"Young","year":"1982","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II \u2014 a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","article-title":"Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II","volume":"100","author":"Rozdzynska","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0060","article-title":"Growth patterns in children with mucopolysaccharidosis I and II","author":"Rozdzynska-Swiatkowska","year":"2014","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymgmr.2013.10.001","article-title":"Growth charts for patients with Hunter syndrome","volume":"1","author":"Patel","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the Hunter Outcome Survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","article-title":"Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II","volume":"34","author":"Schulze-Frenking","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genetics in Medicine"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","article-title":"The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS)","volume":"109","author":"Jones","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0090","first-page":"122","article-title":"Indices of obesity derived from body weight and height","volume":"21","author":"Khosla","year":"1967","journal-title":"Br. J. Prev. Soc. Med."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0095","first-page":"1","article-title":"CDC growth charts: United States","author":"Kuczmarski","year":"2000","journal-title":"Adv. Data"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.41.1.106","article-title":"Head circumference from birth to eighteen years. Practical composite international and interracial graphs","volume":"41","author":"Nellhaus","year":"1968","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_333","article-title":"Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux\u2013Lamy Syndrome)","volume":"18","author":"Quartel","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","article-title":"The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects","volume":"109","author":"Harmatz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2014.09.012","article-title":"Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I","volume":"114","author":"Heppner","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0125","doi-asserted-by":"crossref","unstructured":"L.A. Clarke, Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator Rheumatology (Oxford) 50 Suppl 5 (2011) v13\u201318.","DOI":"10.1093\/rheumatology\/ker395"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002239900656","article-title":"Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI","volume":"65","author":"Nuttall","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0135","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities","volume":"175","author":"Wilson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2012.03.014","article-title":"Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII","volume":"107","author":"Smith","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","article-title":"Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"134A","author":"Swiedler","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2013.06.008","article-title":"Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels","volume":"110","author":"Dung","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet. J. Rare. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10545-013-9658-3","article-title":"Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease)","volume":"37","author":"de Ruijter","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2014.09.009","article-title":"A straightforward, quantitative ultra-performance liquid chromatography\u2013tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses","volume":"114","author":"Zhang","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13023-014-0135-3","article-title":"A modified liquid chromatography\/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses","volume":"9","author":"Chuang","year":"2014","journal-title":"Orphanet. J. Rare. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ab.2014.08.005","article-title":"Quantitative analysis of glycosaminoglycans, chondroitin\/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography\u2013electrospray ionization-tandem mass spectrometry","volume":"467","author":"Osago","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10545-010-9262-8","article-title":"Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H)","volume":"34","author":"Gardner","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0200","series-title":"Foetus Into Man. Physical Growth From Conception to Maturity","author":"Tanner","year":"1989"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0205","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01241398-200107000-00026","article-title":"Growth in pediatric orthopaedics","volume":"21","author":"Dimeglio","year":"2001","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0215","doi-asserted-by":"crossref","unstructured":"J. Karlberg, On the construction of the infancy\u2013childhood\u2013puberty growth standard, Acta Paediatr. Scand. Suppl 356 (1989) 26\u201337.","DOI":"10.1111\/j.1651-2227.1989.tb11237.x"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0220","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/13803395.2013.804035","article-title":"Mucopolysaccharidosis type IIIA presents as a variant of Kluver\u2013Bucy syndrome","volume":"35","author":"Potegal","year":"2013","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/PRM-2010-0120","article-title":"Cartilage and chondrocyte pathology in the mucopolysaccharidoses: the role of glycosaminoglycan-mediated inflammation","volume":"3","author":"Simonaro","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0230","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20515","article-title":"Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses","volume":"125A","author":"Gabrielli","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0240","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3174\/ajnr.A0510","article-title":"Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II","volume":"28","author":"Vedolin","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0245","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3174\/ajnr.A2032","article-title":"Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II","volume":"31","author":"Fan","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0250","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgmr.2015.03.011","article-title":"Enzymatic replacement therapy for Hunter disease: up to 9years experience with 17 patients","volume":"3","author":"Parini","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2016.01.009_bb0260","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ajmg.a.32434","article-title":"Genetic disorders associated with macrocephaly","volume":"146A","author":"Williams","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0265","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4081\/or.2010.e16","article-title":"Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey","volume":"2","author":"Link","year":"2010","journal-title":"Orthop. Rev. (Pavia)"},{"key":"10.1016\/j.ymgme.2016.01.009_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for North American children","volume":"107","author":"Tanner","year":"1985","journal-title":"J. Pediatr."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:36:44Z","timestamp":1718307404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216300087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1096719216300087"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}